Lupin Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is DESOGESTREL, with a corresponding US DMF Number 23619.
Remarkably, this DMF maintains an Active status since its submission on April 12, 2010, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of December 01, 2014, and payment made on November 25, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II